Analysis Tools|
Allele Symbol Allele Name Allele ID |
Il6ratm1.1(IL6R)Csk targeted mutation 1.1, Chugai Pharmaceutical Co Ltd MGI:5556081 |
||||||||||||
| Summary |
2 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• increased in response to human IL6 but not mouse IL6 unlike in wild-type mice that respond to both
|
|
• increased in response to human IL6 but not mouse IL6 unlike in wild-type mice that respond to both
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• prior to and after treatment with MR16-1
• however, treatment with tocilizumab prevents development of splenomegaly
|
|
• however, treatment with tocilizumab prevents development of splenomegaly
|
|
• in the spleen
• however, treatment with ameliorates histological observations
|
|
• however, treatment with ameliorates histological observations
|
|
• prior to and after treatment with MR16-1
• however, treatment with tocilizumab prevents development of splenomegaly
|
|
• however, treatment with tocilizumab prevents development of splenomegaly
|
|
• in the spleen
• however, treatment with ameliorates histological observations
|
|
• however, treatment with ameliorates histological observations
|
|
• prior to and after treatment with MR16-1
• however, treatment with tocilizumab prevents development of splenomegaly
|
|
• however, treatment with tocilizumab prevents development of splenomegaly
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| lymphoproliferative syndrome | DOID:0060704 |
OMIM:PS308240 |
J:207264 | |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|
|
||
